Development and external validation of a clinical prediction model for MRSA carriage at hospital admission in Southeast Lower Saxony, Germany

In countries with low endemic Methicillin-resistant Staphylococcus aureus (MRSA) prevalence, identification of risk groups at hospital admission is considered more cost-effective than universal MRSA screening. Predictive statistical models support the selection of suitable stratification factors for...

Verfasser: Raschpichler, Gabriele
Raupach-Rosin, Heike
Akmatov, Manas
Castell, Stefanie
Rübsamen, Nicole
Feier, Birgit
Szkopek, Sebastian
Bautsch, Wilfried
Mikolajczyk, Rafael
Karch, André
Dokumenttypen:Artikel
Medientypen:Text
Erscheinungsdatum:2020
Publikation in MIAMI:22.02.2023
Datum der letzten Änderung:22.02.2023
Angaben zur Ausgabe:[Electronic ed.]
Quelle:Scientific Reports 10 (2020) 17998, 1-8
Schlagwörter:Epidemiology; Infectious-disease diagnostics; Policy and public health in microbiology
Fachgebiet (DDC):610: Medizin und Gesundheit
Lizenz:CC BY 4.0
Sprache:English
Förderung:Finanziert über die DEAL-Vereinbarung mit Wiley 2019-2022.
Format:PDF-Dokument
URN:urn:nbn:de:hbz:6-71019412185
Weitere Identifikatoren:DOI: 10.17879/81019461853
Permalink:https://nbn-resolving.de/urn:nbn:de:hbz:6-71019412185
Verwandte Dokumente:
  • ist identisch zu:
  • Onlinezugriff:10.1038_s41598-020-75094-6.pdf

    In countries with low endemic Methicillin-resistant Staphylococcus aureus (MRSA) prevalence, identification of risk groups at hospital admission is considered more cost-effective than universal MRSA screening. Predictive statistical models support the selection of suitable stratification factors for effective screening programs. Currently, there are no universal guidelines in Germany for MRSA screening. Instead, a list of criteria is available from the Commission for Hospital Hygiene and Infection Prevention (KRINKO) based on which local strategies should be adopted. We developed and externally validated a model for individual prediction of MRSA carriage at hospital admission in the region of Southeast Lower Saxony based on two prospective studies with universal screening in Braunschweig (n = 2065) and Wolfsburg (n = 461). Logistic regression was used for model development. The final model (simplified to an unweighted score) included history of MRSA carriage, care dependency and cancer treatment. In the external validation dataset, the score showed a sensitivity of 78.4% (95% CI: 64.7–88.7%), and a specificity of 70.3% (95% CI: 65.0–75.2%). Of all admitted patients, 25.4% had to be screened if the score was applied. A model based on KRINKO criteria showed similar sensitivity but lower specificity, leading to a considerably higher proportion of patients to be screened (49.5%).